Cargando…
A double-blind, 377-subject randomized study identifies Ruminococcus, Coprococcus, Christensenella, and Collinsella as long-term potential key players in the modulation of the gut microbiome of lactose intolerant individuals by galacto-oligosaccharides
Background. Our recent publication (Chey et al., Nutrients 2020) showed that a 30-day administration of pure galacto-oligosaccharides (GOS) significantly reduced symptoms and altered the fecal microbiome in patients with lactose intolerance (LI). Results. In this addendum, we performed an in-depth a...
Autores principales: | Azcarate-Peril, M. A., Roach, J., Marsh, A., Chey, William D., Sandborn, William J., Ritter, Andrew J., Savaiano, Dennis A., Klaenhammer, T. R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354614/ https://www.ncbi.nlm.nih.gov/pubmed/34365905 http://dx.doi.org/10.1080/19490976.2021.1957536 |
Ejemplares similares
-
Galacto-Oligosaccharide RP-G28 Improves Multiple Clinical Outcomes in Lactose-Intolerant Patients
por: Chey, William, et al.
Publicado: (2020) -
Prebiotics for Lactose Intolerance: Variability in Galacto-Oligosaccharide Utilization by Intestinal Lactobacillus rhamnosus
por: Arnold, Jason W., et al.
Publicado: (2018) -
Improving lactose digestion and symptoms of lactose intolerance with a novel galacto-oligosaccharide (RP-G28): a randomized, double-blind clinical trial
por: Savaiano, Dennis A, et al.
Publicado: (2013) -
A Narrative Review of Human Clinical Trials to Improve Lactose Digestion and Tolerance by Feeding Bifidobacteria or Galacto-Oligosacharides
por: Mysore Saiprasad, Sindusha, et al.
Publicado: (2023) -
Safety and Modulatory Effects of Humanized Galacto-Oligosaccharides on the Gut Microbiome
por: Arnold, Jason W., et al.
Publicado: (2021)